First Pass

9 stories from 5 sources

Acute health-system crises overshadow tentative treatment advances

Day’s Recap

Supporting Articles

DR Congo has begun vaccinating people against its largest and deadliest Ebola outbreak, with 70,000 Ervebo doses delivered. Health officials hope the vaccine will protect against the outbreak's Bundibugyo strain.

2:13 PMAl Jazeera

Al-Aqsa Martyrs Hospital in Gaza has completely run out of cancer medicines while Israeli strikes continue. Hospital officials warn that patients can no longer access essential treatment.

4:07 PMAl Jazeera

Pakistan has suspended eight officials after an interim inquiry found that an Islamabad hospital lacked adequate fire safety protocols. Authorities have also opened a criminal investigation into the fire that killed 14 babies.

2:26 PMAl Jazeera

Other Developments

A curated list of other prominent stories from this day.

Pattern hair loss affects an estimated 50 million men and 30 million women in the United States. Yet the market has seen no newly approved treatments since the late 1990s.

11:11 AMFortune

In a trial of people with obesity, prediabetes, and fatty liver disease, ketogenic, Mediterranean, and low-fat diets each produced about 10% weight loss. Keto reduced liver fat by 67%, compared with 45% for the other diets, and about half of participants no longer met the threshold for prediabetes after four to five months.

9:32 AMScienceDaily

Indonesia has established shelters for babies and children affected by wildfire smoke, providing a safer setting for vulnerable groups during the pollution event.

8:45 AMAl Jazeera

A large preliminary study found that people with chronic insomnia who used melatonin long term had about a 90% higher risk of developing heart failure over five years. The association does not show that melatonin caused the heart problems.

6:52 AMScienceDaily

A Dutch drug monitoring institute issued a red alert over ecstasy pills shaped like Donald Trump. The pills can have delayed effects, raising the risk that users take more before the first dose has taken effect and overdose.

4:48 AMBBC

A drug recently acquired by Novartis reduced markers of inflammation in testing. The next question is whether that reduction translates into fewer heart attacks and other improved cardiovascular outcomes.

3:32 AMStat News

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!